Micafungin recalls

The FDA has published 5 recalls involving Micafungin since 2018. The latest was reported on 17 Jul 2024. Xellia Pharmaceuticals Usa has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls5since 2018

Last 12 months0reported

Class I00% of total

Ongoing0latest 17 Jul 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 3 60%Class III 2 40%

Why micafungin is recalled

Other Reasons360%
Sterility240%

Companies

By year

2024240%
2021240%
2018120%

All micafungin recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
17 Jul 2024Drug	CLASS III	Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial recalled	Zydus Pharmaceuticals (USA)	Other	Nationwide
17 Jul 2024Drug	CLASS III	Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial recalled	Zydus Pharmaceuticals (USA)	Other	Nationwide
1 Sep 2021Drug	CLASS II	Micafungin for Injection, 50 mg/vial, Single-Dose Vial, Sterile recalled	Xellia Pharmaceuticals Usa	Sterility	Nationwide
1 Sep 2021Drug	CLASS II	Micafungin for Injection, 100 mg/vial, Single-Dose Vial, Sterile recalled	Xellia Pharmaceuticals Usa	Sterility	Nationwide
14 Feb 2018Drug	CLASS II	Mycamine (micafungin) for Injection 100 mg/vial Single-Dose Vial recalledMycamine	Astellas Pharma US	Other	Nationwide

Should you stop taking Micafungin?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.